New hope for CAH: Long-Term drug trial launches
NCT ID NCT06712823
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 21 times
Summary
This study looks at the long-term safety and effectiveness of a drug called atumelnant (CRN04894) for people with classic congenital adrenal hyperplasia (CAH). About 150 adults who have already completed a previous study with this drug will continue treatment. Researchers will monitor side effects, hormone levels, and daily steroid use to see if the drug helps control the condition over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL ADRENAL HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Crinetics Study Site
ACTIVE_NOT_RECRUITINGMorehead City, North Carolina, 28557, United States
-
Crinetics Study Site
RECRUITINGCórdoba, Córdoba Province, 5000, Argentina
-
Crinetics Study Site
RECRUITINGBotucatu, São Paulo, 18618-686, Brazil
-
Crinetics Study Site
RECRUITINGSão Paulo, 05403-000, Brazil
-
Crinetics Study Site
RECRUITINGMunich, Bavaria, 80336, Germany
-
Crinetics Study Site
RECRUITINGRoma, 00161, Italy
-
Crinetics Study Site
RECRUITINGBirmingham, CV22DX, United Kingdom
-
Crinetics Study Site
RECRUITINGLondon, NW1 2BU, United Kingdom
-
Crinetics Study Site, Minneapolis, Minnesota 55454
ACTIVE_NOT_RECRUITINGMinneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.